ECA39 is a novel distant metastasis-related biomarker in colorectal cancer

Abstract

Our results suggest that ECA39 is a dominant predictive factor for distant metastasis in patients with advanced CRC and that its suppression by PSK might represent a useful application of immunotherapy as part of a program of integrated medicine.

References

Page 1

	Year	Citations
Cancer statistics, 2000 Robert T. Greenlee, Thomas S. Murray, S. Bolden, CA A Cancer Journal for Clinicians American Cancer SocietyCancer StatisticsCancer EpidemiologyMedicineGlobal Health	2000	3.9K
The ornithine decarboxylase gene is a transcriptional target of c-Myc. C Bello-Fernández, Graham Packham, John L. Cleveland Proceedings of the National Academy of Sciences Myc ResponsivenessMyc ProteinMolecular BiologyMolecular GeneticsGene Transcription	1993	779
Cdc25 cell-cycle phosphatase as a target of c-myc Konstantin Galaktionov, Xiaocun Chen, David Beach Nature Signal TransductionCell RegulationCell DivisionCdc25 Cell-cycle PhosphataseCell Cycle	1996	693
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer Gillian Smith, Francis A. Carey, Julie Beattie, Proceedings of the National Academy of Sciences	2002	516
Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions Heather Boon, Moira Stewart, Mary Ann Kennard, Journal of Clinical Oncology	2000	442
Association of p53 mutations with short survival in colorectal cancer Richard Hamelin, Pierre Laurent‐Puig, Sylviane Olschwang, Gastroenterology Tumor BiologyP53 MutationsMedicineColorectal CancerPathology	1994	354
Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan Ichinosuke Hyodo, Noriko Amano, Kenji Eguchi, Journal of Clinical Oncology	2005	342
Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer Hiroaki Nakazato The Lancet Surgical OncologyGastrointestinal OncologyMedicineCurative ResectionImmunology	1994	258
Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Reigetsu Yoshikawa, M. Kusunoki, Hidenori Yanagi, PubMed OncologyMedicineMetronomic TherapyPathologyColorectal Cancer	2001	194
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. David Reisman, N. Barry Elkind, B Roy, PubMed Molecular RegulationMolecular BiologyCellular PhysiologyTumor BiologyTranscriptional Regulation	1993	185

Page 1